Biofrontera Inc. SEC filings BFRIW
Biofrontera Inc. has 365 filings in SEC EDGAR's recent list, going back to May 7, 2021. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jul 22, 2026 | — |
| S-1 | Registration statement | Dec 5, 2025 | — |
| S-1/A | Amended registration statement | Aug 13, 2025 | — |
| S-1 | Registration statement | Jul 16, 2025 | — |
| S-1 | Registration statement | Jan 17, 2025 | — |
| S-8 | Employee stock plan registration | Nov 13, 2024 | — |
| S-1 | Registration statement | May 3, 2024 | — |
| S-1/A | Amended registration statement | Mar 20, 2024 | — |
| S-1 | Registration statement | Mar 11, 2024 | — |
| S-1/A | Amended registration statement | Jan 29, 2024 | — |
| S-1 | Registration statement | Jan 17, 2024 | — |
| 424B4 | Prospectus | Nov 1, 2023 | — |
| S-1/A | Amended registration statement | Oct 27, 2023 | — |
| S-1/A | Amended registration statement | Oct 16, 2023 | — |
| S-1 | Registration statement | Oct 5, 2023 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2022 | — |
| S-1 | Registration statement | Nov 3, 2022 | — |
| POS AM | Filing | Jun 10, 2022 | — |
| 424B3 | Prospectus | Jun 9, 2022 | — |
| S-1 | Registration statement | Jun 7, 2022 | — |
| S-8 | Employee stock plan registration | Jun 7, 2022 | — |
| 424B3 | Prospectus | May 13, 2022 | — |
| 424B3 | Prospectus | May 13, 2022 | — |
| 424B3 | Prospectus | Apr 11, 2022 | — |
| 424B3 | Prospectus | Apr 11, 2022 | — |
| 424B3 | Prospectus | Dec 23, 2021 | — |
| S-1 | Registration statement | Dec 21, 2021 | — |
| 424B4 | Prospectus | Nov 1, 2021 | — |
| FWP | Free writing prospectus | Oct 29, 2021 | — |
| S-1/A | Amended registration statement | Oct 26, 2021 | — |
| S-1/A | Amended registration statement | Oct 19, 2021 | — |
| S-1/A | Amended registration statement | Oct 15, 2021 | — |
| S-1/A | Amended registration statement | Oct 14, 2021 | — |
| S-1/A | Amended registration statement | Oct 13, 2021 | — |
| S-1/A | Amended registration statement | Oct 12, 2021 | — |
| FWP | Free writing prospectus | Oct 1, 2021 | — |
| S-1/A | Amended registration statement | Oct 1, 2021 | — |
| S-1/A | Amended registration statement | Sep 16, 2021 | — |
| S-1/A | Amended registration statement | Aug 31, 2021 | — |
| S-1/A | Amended registration statement | Aug 12, 2021 | — |
| S-1/A | Amended registration statement | Jul 26, 2021 | — |
| S-1 | Registration statement | Jul 6, 2021 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BFRI (Nasdaq), BFRIW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woburn, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1858685
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.